✅ Manages lipid levels
✅ Controls blood sugar
✅ Reduces cardiovascular risk
✅ Improves insulin sensitivity
✅ Enhances metabolic health

Lipaglyn contains Saroglitazar.

Product Overview

Lipaglyn is a medication containing the active ingredient Saroglitazar. It is a novel peroxisome proliferator-activated receptor (PPAR) agonist with dual alpha and gamma activity. Lipaglyn is specifically formulated for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes mellitus. It works by regulating lipid metabolism, reducing triglyceride levels, and improving insulin sensitivity, thus helping to manage lipid abnormalities commonly associated with diabetes.


Lipaglyn is indicated for the treatment of diabetic dyslipidemia, a condition characterized by abnormal lipid levels in individuals with type 2 diabetes. It is also prescribed for the management of hypertriglyceridemia, a condition marked by elevated triglyceride levels in the blood, which can increase the risk of cardiovascular disease. Lipaglyn helps improve lipid profiles and reduces the risk of cardiovascular complications in diabetic patients.

How to Use

Lipaglyn should be taken orally as directed by a healthcare professional. The recommended dosage is usually one tablet once daily, with or without food. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. It is important to adhere to the prescribed dosage regimen and not to exceed the recommended dose without consulting a doctor.

How it Works

The active ingredient Saroglitazar in Lipaglyn works by activating both alpha and gamma PPAR receptors in the liver and skeletal muscle cells. This dual agonistic action helps regulate lipid metabolism by increasing fatty acid oxidation, reducing hepatic glucose production, and enhancing insulin sensitivity. As a result, Lipaglyn helps decrease triglyceride levels, increase high-density lipoprotein (HDL) cholesterol levels, and improve overall lipid profiles in patients with type 2 diabetes mellitus.

Dosage and Administration

The recommended dosage of Lipaglyn is one tablet (4 mg) taken orally once daily. It can be taken with or without food. Patients should follow the dosage regimen prescribed by their healthcare provider and should not exceed the recommended dose. Lipaglyn may be used as monotherapy or in combination with other lipid-lowering medications, depending on the individual patient’s needs.


Lipaglyn offers several benefits for patients with type 2 diabetes and dyslipidemia, including the reduction of triglyceride levels, improvement of HDL cholesterol levels, and enhancement of insulin sensitivity. By addressing lipid abnormalities, Lipaglyn helps reduce the risk of cardiovascular complications associated with diabetes and promotes better overall metabolic health.

Common Side Effects

Common side effects associated with Lipaglyn may include headache, dizziness, nausea, abdominal pain, diarrhea, and fatigue. These side effects are usually mild and transient, and they typically resolve on their own with continued use of the medication. However, patients experiencing persistent or severe side effects should seek medical attention promptly.


Lipaglyn should be used with caution in patients with a history of liver disease or renal impairment, as it may exacerbate these conditions. It is not recommended for use in pregnant or breastfeeding women due to potential risks to the fetus or infant. Patients should undergo regular monitoring of liver function tests and renal function tests while taking Lipaglyn. Additionally, Lipaglyn may interact with certain medications, so patients should inform their healthcare provider about all the medications they are taking.

Storage Information

Lipaglyn should be stored at room temperature away from moisture and heat. It should be kept out of reach of children and pets. Unused or expired medication should be properly disposed of according to local regulations or guidelines.


Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.


30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s


There are no reviews yet.

Be the first to review “Lipaglyn”